PHASE II STUDY OF THE HISTONE-DEACIETYLASE INHIBITOR ITF2357 IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA PATIENTS

被引：0
|
作者：
Bonfante, V. [1 ]
Viviani, S. [1 ]
Fasola, C. [1 ]
Crippa, F. [1 ]
Marchiano, A. [1 ]
Valagussa, P. [1 ]
Gianni, A. M. [1 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0605
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
    Maruyama, Dai
    Hatake, Kiyohiko
    Kinoshita, Tomohiro
    Fukuhara, Noriko
    Choi, Ilseung
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Terui, Yasuhito
    Higuchi, Yusuke
    Onishi, Yasushi
    Abe, Yasunobu
    Kobayashi, Tsutomu
    Shirasugi, Yukari
    Tobinai, Kensei
    CANCER SCIENCE, 2017, 108 (05) : 1007 - 1012
  • [32] Phase II study of oxaliplatin in patients with relapsed or refractory non-Hodgkin's lymphoma: Final results.
    Oki, Y
    McLauhlin, P
    Pro, B
    Hagemeister, FH
    Bleyer, A
    Loyer, E
    Younes, A
    BLOOD, 2004, 104 (11) : 684A - 684A
  • [33] Resminostat In Relapsed or Refractory Hodgkin Lymphoma: Initial Results of the SAPHIRE Phase II Trial with a Novel Oral Histone Deacetylase (HDAC) Inhibitor
    Walewski, Jan
    Paszkiewicz-Kozik, Ewa
    Borsaru, Gabriela
    Moicean, Andreea
    Warszewska, Agnieszka
    Strobel, Klaus
    Biggi, Alberto
    Hauns, Bernhard
    Mais, Anna
    Henning, Stefan W.
    Hentsch, Bernd
    BLOOD, 2010, 116 (21) : 1159 - 1159
  • [34] Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
    Oki, Yasuhiro
    Fanale, Michelle
    Romaguera, Jorge
    Fayad, Luis
    Fowler, Nathan
    Copeland, Amanda
    Samaniego, Felipe
    Kwak, Larry W.
    Neelapu, Sattva
    Wang, Michael
    Feng, Lei
    Younes, Anas
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 463 - 470
  • [35] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
  • [36] Phase II Study of an AKT Inhibitor MK2206 in Patients with Relapsed or Refractory Lymphoma
    Oki, Yasuhiro
    Fanale, Michelle A.
    Romaguera, Jorge E.
    Fayad, Luis
    Fowler, Nathan
    Copeland, Amanda R. M.
    Samaniego, Felipe
    Kwak, Larry W.
    Neelapu, Sattva S.
    Wang, Michael
    Feng, Lei
    Younes, Anas
    BLOOD, 2014, 124 (21)
  • [37] Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
    Maruyama, Dai
    Terui, Yasuhito
    Yamamoto, Kazuhito
    Fukuhara, Noriko
    Choi, Ilseung
    Kuroda, Junya
    Ando, Kiyoshi
    Hattori, Akira
    Tobinai, Kensei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (11) : 1265 - 1273
  • [38] A Phase II Multicenter Single Arm Study of Ibrutinib in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
    Ramchandren, Radhakrishnan
    Phillips, Tycel J.
    Devata, Sumana
    Gabali, Ali M.
    Houde, Christiane
    Pregja, Silva
    Aghamohammadi, Golbon
    Wesson, Emily
    Hutto, Tony
    Fanale, Michelle A.
    BLOOD, 2017, 130
  • [39] Phase II study of sorafenib in patients with relapsed or refractory lymphoma
    Guidetti, Anna
    Carlo-Stella, Carmelo
    Locatelli, Silvia L.
    Malorni, Walter
    Pierdominici, Marina
    Barbati, Cristiana
    Mortarini, Roberta
    Devizzi, Lilli
    Matteucci, Paola
    Marchiano, Alfonso
    Lanocita, Rodolfo
    Farina, Lucia
    Dodero, Anna
    Tarella, Corrado
    Di Nicola, Massimo
    Corradini, Paolo
    Anichini, Andrea
    Gianni, Alessandro M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (01) : 108 - 119
  • [40] A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma
    Cohen, Jonathon Brett
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia A.
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345